CH
GenScript Biotech Global Forum
Cell & Gene Therapy and the Booming China Market
Grand Ballroom, Grand Hyatt San Francisco
Tuesday, January 14, 2020
CH
Cell & gene therapy have gained prominence in the biotechnology industry in recent years, creating hope for a new era of cancer treatment. The promise of these new treatments has attracted global attention and is offering vast opportunities for innovation and capital investment. To examine these opportunities, GenScript is pleased to launch its inaugural GenScript Biotech Global Forum, which will take place on Tuesday, Jan. 14 at the Grand Hyatt San Francisco Hotel during the 2020 JP Morgan Healthcare Conference.
Exploring the theme of "Cell & Gene Therapy and the Booming China Market,",GenScript aims to build a bridge between the cell and gene therapy research and development field and the capital community. The forum will bring together leading academic and industry professionals, experienced investors and international regulatory authorities to discuss topics such as how to forge global collaborations and how to accelerate regulatory approvals to bring life-saving products to patients more quickly. Join us in San Francisco this year at what promises to be a unique opportunity to share insights and collaborate on the global advancement of cell and gene therapy.
14：00 - 14：05 ●
Sally Wang, co-founder, Executive Director and President, GenScript Biotech
14：05 - 14：15 ●
Frank Zhang, Ph.D., Founder, Chairman and CEO, GenScript Biotech
14：15 - 14：55 ●
Scott Gottlieb, M.D., Former FDA Commissioner
14：55 - 15：35 ●
Moderator: Usman Azam, M.D., CEO, Tmunity Therapeutics
Panelist:
Peter Emtage, Ph.D., Global Head of Cell Therapy Research, Kite Pharma, a Gilead Company
Phil Vanek, Ph.D., GM of Cell and Gene Therapy Strategy and Business Development, GE Healthcare Life Sciences
Frank Fan, M.D., Ph.D. ,CSO, Legend Biotech
Laurence Cooper, M.D., Ph.D. ,CEO , Ziopharm Oncology
Dan Wang, M.D., Head, Johnson & Johnson Innovation Asia Pacific
Zonghai Li, M.D., Ph.D.,CEO&CSO, CARsgen Therapeutics
15：35 - 16：15 ●
Moderator:Simone Fishburn, Ph.D., VP and Editor in Chief, BioCentury
Panelist:
Guangping Gao, Ph.D., President of American Society of Gene & Cell Therapy, Professor of University of Massachusetts Medical School
John Dawson, CEO, Oxford Biomedica
Frederic Revah, Ph.D., CEO, Genethon
Brian Min, Ph.D., CEO, GenScript Biotech Biological Drug Business Unit
Richard Wang, Ph.D., CEO, Fosun Kite
James Li, CEO and Co-founder, JW Therapeutics
16：15 - 16：55 ●
Moderator: James Huang, Founding Partner of Panacea Venture , Managing Partner of KPCB China
Panelist:
Brad Loncar, Founder &CEO , Loncar Investment
Robin Meng, Executive Director, GenScript Biotech
Hongbo Lu, Ph.D., Managing Partner, Lilly Asia Ventures
Bin Li, Ph.D., Founder and Chief Investment Officer, Lake Bleu Capital
Mark Tang，Managing Director, Founding Partner , Good Health Capital
Ling Zhang, Head of Healthcare and Technology Investment, JPMorgan
16：55 - 17：35 ●
Moderator: Becky Wood, Head of Sidley's Food, Drug and Medical Device Regulatory Practice, Former Chief Counsel of FDA
Panelist:
Alex Xu, M.D., Ph.D., Chief Scientist, CFDA/CDE
Ke Liu, MD, Ph.D., Associate Director for Cell and Gene Therapy, Oncology Center of Excellence & Chief of Oncology Branch, FDA
Li Zhu, Ph.D., Chief Strategy Officer, GenScript Biotech
Gang Wang, Ph.D., Chief Quality Officer and Senior Vice President, Shanghai Junshi Biosciences
17：35 - 17：55 ●
Xiumei Miao, Deputy District Mayor, Nanjing Jiangning Government
17：55 - 18：00 ●
Sally Wang, co-founder, Executive Director and President, GenScript Biotech
18：00 - 20：00 ●
Usman Azam, M.D.
CEO, Tmunity Therapeutics
Laurence Cooper, M.D., Ph.D.
CEO, Ziopharm Oncology
John Dawson
CEO, Oxford Biomedica
Peter Emtage, Ph.D.
Global Head of Cell Therapy Research,
Kite Pharma, a Gilead Company
Frank Fan, M.D., Ph.D.
CSO, Legend Biotech
Simone Fishburn, Ph.D.
Vice President and Editor in Chief, BioCentury
Guangping Gao, Ph.D.
President of American Society of
Gene and Cell Therapy,
Professor of University of
Massachusetts Medical School
Scott Gottlieb, M.D.
Former FDA Commissioner
James Huang
Founding Partner of Panacea Venture,
Managing Partner of KPCB
Bin Li, Ph.D.
Founder and Chief Investment Officer,
Lake Bleu Capital
Ke Liu, M.D., Ph.D.
Associate Director for Cell and
Gene Therapy, Oncology Center of
Excellence & Chief of Oncology Branch, FDA
James Li
CEO and Co-founder,
JW Therapeutics
Zonghai Li, M.D., Ph.D.
Executive Chairman, CEO&CSO and Founder, CARsgen Therapeutics
Brad Loncar
Founder &CEO, Loncar Investment
Hongbo Lu, Ph.D.
Managing Partner, Lilly Asia Ventures
Robin Meng
Executive Director,
GenScript Biotech Corporation
Xiumei Miao
Deputy District Mayor,
Nanjing Jiangning Government
Brian Min, Ph.D.
CEO, GenScript Biotech Biological Drug Business Unit.
Frédéric Revah Ph.D.
CEO, Généthon
Mark Tang，Ph.D.
Managing Director, Founding Partner, Good Health Capital New York
Phil Vanek, Ph.D.
GM of Cell and Gene Therapy Strategy and Business Development, GE Healthcare Life Sciences
Dan Wang, M.D.
Head, Johnson & Johnson Innovation Asia Pacific
Gang Wang, Ph.D.
Chief Quality Officer and Senior Vice President, Shanghai Junshi Biosciences
Richard Wang, Ph.D.
CEO, Fosun Kite Biotechnology
Sally Wang
Co-founder, Executive Director, President, GenScript Biotech Corporation
Becky Wood
Head of Sidley's Food, Drug and Medical Device Regulatory Practice, Former Chief Counsel of FDA
Alex Xu, M.D., Ph.D.
Chief Scientist, CFDA/CDE
Frank Zhang, Ph.D.
Founder, Chairman and CEO，GenScript Biotech Corporation
Ling Zhang
Managing Director, Head of China Healthcare Investment Banking, J.P. Morgan
Li Zhu, Ph.D.
Chief Strategy Officer,
GenScript Biotech Corporation
许远
传奇生物CEO
Lynn J. Rothschild
NASA Ames Research Center
Nathan Hillson
Joint BioEnergy Institute
Rhiju Das
Stanford University
许远
传奇生物CEO
Lynn J. Rothschild
NASA Ames Research Center
Nathan Hillson
Joint BioEnergy Institute
Rhiju Das
Stanford University
